¶¶زُ¶جتسئµ

header-logo
GettyImages-609179959-hero
headshot

Karen-Sue B. Carlson, MD, PhD

Associate Professor

view physician profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital
  • Moorland Reserve Health Center

Specialties

  • Medical Oncology
  • Hematology

Languages

  • English

Clinical Cancer Center - Froedtert Hospital

Moorland Reserve Health Center

Education

  • MD - Doctor of Medicine
  • PhD

Biography

Karen-Sue Barker Carlson, MD, PhD, is an assistant professor of medicine at the ¶¶زُ¶جتسئµ, Division of Hematology and Oncology, specializing in acute and chronic myeloid leukemia, adolescent and young adult leukemia, myelodysplastic syndromes and myeloproliferative disorders. She received her MD and PhD in 2004 from the University of Wisconsin – Madison. In 2006, she completed her postdoctoral fellowship at The Rockefeller University in New York. She was awarded the F.M. Kirby Postdoctoral Fellowship in Sensory Neuroscience during her fellowship. Dr. Carlson completed her residency in internal medicine and subsequent Fellowship in Hematology and Medical Oncology at Weill Cornell Medical Center, New York Presbyterian Hospital, New York. In her final year, Dr. Carlson served as Chief Hematology and Oncology Fellow. Dr. Carlson held the position of Assistant Professor, Department of Medicine, Division of Hematology and Oncology at Weill Cornell Medical Center prior to joining ¶¶زُ¶جتسئµ.

Research Interests

Dr. Carlson's basic and clinical research focus on the bone marrow microenvironment and its impact on normal and leukemic blood cell production. Dr. Carlson is board certified in Internal Medicine and Hematology.

Publications

  • (Kranjac CA, Hobbs LM, Feustel K, Carlson KS.) J Med Cases. 2025 May;16(5):187-193 PMID: 40503540 PMCID: PMC12151121 06/12/2025

  • (Abedin SM, Guru Murthy GS, Hamadani M, Michaelis LC, Carlson KS, Runaas L, Gauger K, Desai AG, Chen MM, Li KL, Rotibi M, Syed U, Vusirikala M, Harrington A, Atallah EL.) Leukemia. 2025 Apr;39(4):837-843 PMID: 39955432 SCOPUS ID: 2-s2.0-85218187693 02/16/2025

  • (Carlson KS, Cunningham A, Stahl M, Winer E, Michaelis LC.) Acta Haematol. 2024;147(2):122-132 PMID: 38071966 12/11/2023

  • (Zhang Y, Lin D, Zheng Y, Chen Y, Yu M, Cui D, Huang M, Su X, Sun Y, Chen Y, Qian Z, Carlson KS, Wen R, Wang D.) Leukemia. 2023 Nov;37(11):2261-2275 PMID: 37670087 PMCID: PMC10844005 SCOPUS ID: 2-s2.0-85169811460 09/06/2023

  • (Kleman A, Singavi A, Pommert L, Mathison AJ, Hari P, Dhakal B, Mohan M, Janz S, Knight JM, Shah MV, Schinke C, Burns R, Steinhardt GF, Rao S, Carlson K.) Blood Adv. 2023 Sep 26;7(18):5549-5553 PMID: 36724511 PMCID: PMC10514068 SCOPUS ID: 2-s2.0-85164933174 02/02/2023

  • (Zhang T, Auer P, Dong J, Cutler C, Dezern AE, Gadalla SM, Deeg HJ, Nazha A, Carlson KS, Spellman S, Bolon YT, Saber W.) J Hematol Oncol. 2023 Apr 11;16(1):37 PMID: 37041565 PMCID: PMC10088148 SCOPUS ID: 2-s2.0-85152260295 04/12/2023

  • (Zorn KE, Cunningham AM, Meyer AE, Carlson KS, Rao S.) Cancers (Basel). 2023 Feb 24;15(5) PMID: 36900239 PMCID: PMC10000481 03/12/2023

  • (Ramadan R, Wouters VM, van Neerven SM, de Groot NE, Garcia TM, Muncan V, Franklin OD, Battle M, Carlson KS, Leach J, Sansom OJ, Boulard O, Chamaillard M, Vermeulen L, Medema JP, Huels DJ.) Biol Open. 2022 Dec 15;11(12) PMID: 36350252 PMCID: PMC9713296 SCOPUS ID: 2-s2.0-85142918558 11/10/2022

  • (Abedin SM, Badar T, Gauger K, Michaelis LC, Runaas L, Carlson KS, Murthy GG, Atallah E.) Leuk Res. 2022 Dec;123:106984 PMID: 36401944 SCOPUS ID: 2-s2.0-85141943453 11/20/2022

  • (Johnson AK, Lorimer EL, Szabo A, Wu R, Shah NN, D'Souza A, Chhabra S, Hamadani M, Dhakal B, Hari P, Rao S, Carlson K, Williams CL, Knight JM.) Yale J Biol Med. 2022 Mar;95(1):45-56 PMID: 35370486 PMCID: PMC8961707 SCOPUS ID: 2-s2.0-85127524780 04/05/2022

  • (Khan M, Roddy JT, Hernandez JR, Bursch K, Bal N, Carlson KS, Bergl PA.) Br J Haematol. 2021 Sep;194(6):1083-1085 PMID: 34101165 06/09/2021

  • (Wang W, Auer P, Zhang T, Spellman S, Carlson KS, Nazha A, Bolon YT, Saber W.) Transplant Cell Ther. 2021 Aug;27(8):659.e1-659.e6 PMID: 33992829 PMCID: PMC8421055 SCOPUS ID: 2-s2.0-85108524869 05/17/2021

Publications of from the

© 2025 ¶¶زُ¶جتسئµ.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The ¶¶زُ¶جتسئµ (¶¶زُ¶جتسئµ) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. ¶¶زُ¶جتسئµ maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

¶¶زُ¶جتسئµ's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the ¶¶زُ¶جتسئµ community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.